Inhaled corticosteroids are strongly recommended, in addition to streamlined management with combination and step-up therapy
TUESDAY, Feb. 17, 2026 (HealthDay News) — In a synopsis of a clinical practice guideline issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Feb. 17 in the Annals of Internal Medicine, updated recommendations are presented for the primary care management of asthma in veterans and military members.
Amir Sharafkhaneh, M.D., Ph.D., from the Michael E. DeBakey VA Medical Center in Houston, and colleagues present updated recommendations regarding evaluation and management of veterans and military members with asthma. Twelve key questions were developed, and 21 evidence-based recommendations were advanced following evaluation of the evidence.
The authors note that inhaled corticosteroids are strongly recommended; management of asthma is streamlined with recommendations of a combination of inhaled corticosteroids and rapid-onset long-acting β-agonists as both reliever and controller agents, as well as step-up therapy by increasing inhaled corticosteroids and/or the addition of long-acting anticholinergic agents. Management of symptomatic gastroesophageal reflux disease and obesity are also supported for better control of asthma. Use of indoor air filtration devices is not suggested. Decision points are outlined for referral to a subspecialist.
“Asthma management within primary care is pivotal for enhancing patient outcomes and reducing health care burdens,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Exacerbation Risk Profiles Vary With House Dust Mite Sensitization in Pediatric Asthma
Eosinophilic Esophagitis Prevalence May Be Higher Than Thought in Pediatric Patients With Asthma
Significant Changes in Voice Noted
During Exacerbation of Asthma, COPD
Vitamin A, D May Aid Asthma Outcomes
Early Respiratory Infections Linked to Atopic Dermatitis Diagnosis
Cognitive, Manual Impairment Tied to Unacceptable Inhaler Technique
Consensus Statements Developed for Rheumatoid Arthritis-Linked Interstitial Lung Disease
Racial, Ethnic Differences Seen in Inhaler Use for Asthma in U.S. Adults